Objective: Increased knowledge of breast cancer risk factors enables a shift from one-size-fits-all breast cancer screening to a risk-based approach, tailoring screening policy to a woman's individual risk. New opportunities for prevention will arise.
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acceptability, attitudes, breast cancer, oncology, prevention, risk prediction, risk stratification, screening 1 | BACKGROUND Population-based breast cancer screening programs, adhering to a one-size-fits-all approach based on age, have successfully led to early detection and subsequent breast cancer mortality reduction. 1, 2 However, screening may become more effective if tailored to women's differing levels of breast cancer risk, potentially optimizing the benefit-harm ratio of screening. 3 Breast cancer risk prediction models are becoming more accurate by adding, eg, breast density and polygenic risk score to classic risk factors. 4 Risk prediction also offers new opportunities for breast cancer prevention, targeting women who would benefit most from reducing their risk through lifestyle changes or risk-reducing medication. Successful implementation of risk-based screening and prevention relies on women's participation. However, eligible women's perceptions of adopting this novel program have never been explored.
A risk-based screening and prevention program is inherently more complex than current age-based screening programs. Women need to reflect on participation at different stages ( Figure 1 ). Although Figure 1 is an illustration which does not necessarily follow current pathways of care, it shows that women need to decide whether they (a) want to know their risk, (b) are willing to change their screening strategy based on risk, and (c) are prepared to participate in preventative practices. Women's interest in knowing their breast cancer risk is high. 5 However, knowledge of their risk did not lead to any consistent changes in screening or preventative behaviours. 6 Additionally, although women generally appear in favor of increased screening for high-risk women, lowering screening intensity for low-risk women is more contested. 7, 8 Women are concerned about the accuracy of breast cancer risk estimates with some believing that risk-based screening is mainly motivated by a desire to save money. 8 Their perceptions of prevention also seem mixed. 7 However, risk-reducing medication has mostly been discussed with high-risk women who tend to be monitored outside of national screening programs, which potentially limits the generalizability of these results to the screening population.
Risk-based screening may bring about considerable benefits to healthcare policy by directing screening and preventative resources to women who are most in need. 9 However, there is a lack of knowledge on the acceptability of an integrated risk-based breast cancer screening and prevention program from the perspective of the three countries. Therefore, we were able to identify five superordinate themes: (1) impact of knowledge, (2) belief in science, (3) emotional impact, (4) decision making, and (5) attitude to medication.
Although the overarching themes showed similarities, subthemes sometimes differed per country. Both will be discussed below using FG data extracts.
| Theme 1. Impact of knowledge (NL, SE, and UK)
The superordinate theme "impact of knowledge" deals with women's perception that once they know their breast cancer risk, they feel the need to act upon that information. A moderate-high risk result in particular elicited either a beneficial response, ie, the subthemes perceived control, proactive attitude, motivation, and empowerment, or was perceived as a burden, ie, avoidance, guilt, and fatalistic view. As a Swedish participant put it, "A high risk result almost feels like it's close to a diagnosis." British participants, who had chosen to have their breast cancer risk relayed, generally perceived knowledge of risk as an opportunity: "Perhaps being more aware, and doing something proactively about your high risk, makes you feel more in control, and so you're less stressed." Although women in all three countries generally welcomed preventative options to manage their risk, they also mentioned the potential for stigma and guilt, eg, "It puts a lot of responsibility for health on women and not everyone is equally capable of maintaining a healthy lifestyle; financially or intellectually.
It can't become a woman's own fault if she develops breast cancer"
(Dutch participant).
| Theme 2. Belief in science (NL, SE, and UK)
The superordinate theme "belief in science" illustrates women's concerns regarding the scientific basis of the risk prediction model and the effectiveness of risk-reducing medication and lifestyle changes.
Dutch women were particularly concerned about extending the screening interval for women at below average risk, wondering whether it is financially motivated rather than evidence-based. 
| Theme 3. Emotional impact (NL and UK)
The superordinate theme "emotional impact" describes how women think risk-based screening and prevention will affect their psychologi- 
| Theme 5. Attitude to medicine (NL and UK)
The superordinate theme "attitude to medicine" reflects the apparent controversial nature of risk-reducing medication for breast cancer, which was mostly addressed by British and Dutch women. Swedish women tended to have a more pragmatic approach to medication, stating that they preferred lifestyle changes but that they would be willing to try medication to determine the level of adverse effects.
Most Dutch women, however, expressed an aversion to medication, perceiving it to be a radical and unnecessary daily hassle when dealing with a risk instead of a diagnosis. Anecdotal knowledge of particularly tamoxifen as a breast cancer drug induced worry and anxiety. Some The superordinate themes associated with women's perceptions of risk-based screening and prevention across the three countries are rooted in behavioral theory. Women's perceptions seem to be best reflected by the "health belief model" and "self-determination theory". 12, 13 These two theoretical frameworks assume a cost-benefit analysis of particular health behaviors, whereby a person takes into account perceived severity and susceptibility to disease, psychological factors, social context, autonomy, and personal competence. The relevance of these two frameworks to the adoption of this novel screening and prevention paradigm by women has previously been demonstrated. 7 However, the way in which the underlying constructs of the theoretical frameworks are represented in women's perceptions sometimes differs across the three countries, potentially pointing to culture-specific attitudes or customs.
Cross-cultural concordance was seen in the themes "impact of knowledge" and "belief in science". Women from all three countries deliberated that breast cancer risk information may not be without consequence, enticing activity, or potential emotional turbulence.
The importance of perceived competence in health behavior decision making is highlighted. Dutch and Swedish women reported a great need to understand the scientific basis of the risk prediction model and subsequent screening and prevention recommendations. They appear to perceive a greater sense of control when more knowledgeable. However, research shows that risk information is difficult to understand. 14 A comprehensive information leaflet, which meets all of women's perceived information needs, may therefore hinder informed decision making. This is in accordance with the attitude of British women in this study who only received a basic level of information at every stage of the program but did not report a perceived lack of information or knowledge. The theme "belief in science" also highlighted some women's skepticism about the accuracy of risk estimates and the rationale behind risk-based screening, suspecting a financial motive. These concerns were previously mentioned by US women who professed a reluctance to change current screening habits, fearing missed breast cancers with a changed screening interval. 8 The emotional impact of risk assessment was hypothesized by Dutch women and reported by British women about a year after receiving risk feedback. Some British women who were classified as moderate-high risk reported a decrease in psychological well-being with some women seeking professional help. These findings are tentatively confirmed by a survey study among PROCAS participants who received breast cancer risk feedback and PROCAS participants who were awaiting their risk feedback. 6 Women who had received their risk feedback reported lower levels of anxiety but higher levels of cancer worry than women awaiting their risk feedback. Additionally, women with a moderate-high risk of developing breast cancer reported higher anxiety than women with a below average risk. However, overall anxiety levels were still relatively low. This is in line with previous research showing no significant long-term impact of genetic risk estimation on psychological outcomes.
15
A pronounced difference between Swedish and British women's perceptions was visible in the decision making process precipitating participation. Swedish participants favored a more autonomous process than British participants, who emphasized a shared approach.
Previous studies have found that medical decision making is affected by gender, age, and education, with younger, highly qualified women being most likely to desire higher levels of autonomy. 16 This partially corresponds with our findings since Swedish women were, on average, more educated than British women. However, Swedish women were also considerably older on average than British women, contradicting previous findings. Moreover, a qualitative study of Swedish people's values regarding participation in colorectal cancer screening showed a similar need for autonomy, pointing to a potential societal attitude.
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The superordinate theme "attitude to medicine" shows a general reluctance of women to try risk-reducing medication. Particularly noteworthy is the reliance of British women on professional endorsement in the decision making process. Although our British participants were generally not in favor of medication, professional endorsement changed their views almost unanimously. This is in concordance with previous research suggesting that people look to physicians for decisions on medication use, because of their perceived superior knowledge. 16 It is unclear whether the unfavorable opinion of Dutch and Swedish women regarding risk-reducing medication is related to the hypothetical nature of the risk scenarios. However, Dutch women are known for their reluctance to take medication, 17 which is supported by the relatively low number of women reporting current/past HRT use in this study. Breast cancer risk reduction through medication is notoriously difficult to achieve, with few women showing willingness to commit to a 5-year preventative treatment regimen. 18, 19 The use of tamoxifen as a preventative drug elicits a strong response from women because of the association with breast cancer treatment. 20 Additionally, the perceived adverse effects often deter women, 19, 20 which was confirmed in the present study.
Currently, studies are being undertaken, eg, KARMA Intervention Study (KARISMA) in SE (https://karmastudy.org/ongoing-research/), to determine the lowest effective dose of tamoxifen to potentially increase its applicability as a preventative drug.
| CONCLUSIONS

| Study limitations
The present study is the first exploration of European women's per- 
| Clinical implications
Acceptability of risk-based screening and prevention is mixed. More intensive screening for women with above average breast cancer risk was generally welcomed. However, screening pathways for the other risk categories and general prevention strategies were met with some skepticism. This has implications for clinical practice that need to be addressed by stakeholders and policy makers before implementation.
Women's perceptions seem to be informed by a lack of knowledge, cultural norms, and common emotional concerns, which highlights the importance of tailored educational materials and risk counselling to aid either shared or individual informed decision making.
